Using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS), a Polish research team discovered interesting new insights into the changes in sphingolipid metabolism in patients with early-stage primary biliary cholangitis (PBC). The findings encourage further research into the potential benefits of sphingolipids as biomarkers and targets in cholestatic liver diseases, the authors conclude.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Neuro-ophthalmology
Visual Snow Syndrome: From the mysterious disorder to effective treatment options
- Platelet and leukocyte abnormalities
Clonal or reactive causes?
- Gonarthrosis and coxarthrosis: update on conservative treatment
Pain relief, targeted movement and relief
- Idiopathic and progressive pulmonary fibrosis (IPF/PPF)
An instrument for clinical use
- Rosacea - multifaceted and multifactorial
Topical and systemic active ingredients: proven and new therapeutic approaches
- Lung cancer
Multidisciplinary teams in oncology
- From diagnostics to personalized therapy
Nuclear medical imaging for Parkinson’s disease
- Psoriasis in difficult localizations: Nail psoriasis